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In This IssueReview Focus: Cancer Stem Cells
KRESO AND DICK, 275, OSKARSSON ET AL., 306 AND MIHAYLOVA ET AL., 292
This issue features a series of Reviews on cancer stem cells. Kreso and
Dick present a harmonizedmodel of cancer that incorporates both genetic
clonal evolution and cancer stem cell theories with a focus on therapeutic
implications. Mihaylova et al. examine the role of diet and metabolic regu-
lation in normal and tumorigenic stem cells, and Oskarsson et al. discuss
cancer stem cells in the context of metastasis and tumor niches.Talen-Mediated Mutagenesis
LIU ET AL., 323
This paper reports successful TALEN-mediated targeting of the MECP2
gene in rhesus and cynomolgus monkeys with no evidence of off-target
activity and embryonic lethality of mutant male fetuses similar to that
seen in humans. (Top Image.)Leukemia Stem Cells Maintained by Mutant IHD2
KATS ET AL., 329
Mutant IDH2 drives self-renewal of HSPCs and co-operates with oncogenes FLT3 or HoxA9 and Meis1 to drive initiation of
leukemia in vivo.Colon Cancer Metastasis
TODARO ET AL. 342
In response to niche signals, colorectal cancer stem cells upregulate an isoform of CD44 (CD44v6) that is required for their
migration and ability to generate metastatic tumors. (Bottom Image.)Glioma in the Perivascular Niche
PIETRAS ET AL., 357
Osteopontin is expressed in the glioma perivascular niche and activates CD44 signaling, which drives tumor growth and
promotes glioma stem cell phenotypes via CBP/p300-mediated enhancement of HIF-2a.Reprogramming to Hepatocytes
HUANG ET AL., 370 AND DU ET AL., 394
Huang et al. demonstrate direct conversion of human fibroblasts to hepa-
tocyte-like cells, which can be expanded in culture and used to treat acute
liver failure and metabolic liver disease, and Du et al. combine maturation
factors with hepatic fate conversion factors to reprogram human fibroblasts
into induced hepatocytes with functional drug metabolism. Preview by
Vallier.Haploid ESCs Chart New Territory
LI ET AL., 404 AND LEEB ET AL., 385
Li et al. generate androgenetic rat haploid embryonic stem cells that can be
used for genetic screening, random or homologous mutategenesis, and
CRISR/Cas-mediated gene targeting, and Leeb et al. identify key players
regulating exit from self-renewal in ESCs using a forward genetic screen
in haploid ESCs. Preview by Kokubi and Takeda.Cell Stem Cell 14, March 6, 2014 ª2014 Elsevier Inc. xi
